| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Sr VP, Clinical Research &Dev
1 company
Bryce Richard Paul is a See Remarks at PUMA BIOTECHNOLOGY, INC.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $978K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 20, 2018 | PBYI Puma Biotechnology, Inc. | See Remarks | Sell | 1,836 | $51.95 | $95,381.30 | -5.3% | |
| Jan 22, 2018 | PBYI Puma Biotechnology, Inc. | Sr VP, Clinical Research &Dev | Sell | 1,860 | $92.75 | $172,515.00 | -6.8% | |
| Sep 29, 2017 | PBYI Puma Biotechnology, Inc. | Sr VP, Clinical Research &Dev | Sale+OE | 15,000 | $120.00 | $1,800,000.00 | -35.5% | |
| Sep 7, 2017 | PBYI Puma Biotechnology, Inc. | Sr VP, Clinical Research &Dev | Sale+OE | 15,000 | $100.09 | $1,501,400.00 | -21.6% | |
| Jul 20, 2017 | PBYI Puma Biotechnology, Inc. | Sr VP, Clinical Research &Dev | Sell | 1,998 | $94.48 | $188,777.28 | -3.5% | |
| Jul 3, 2017 | PBYI Puma Biotechnology, Inc. | Sr VP, Clinical Research &Dev | Sale+OE | 5,000 | $87.10 | $435,500.00 | -14.6% | |
| Jan 20, 2017 | PBYI Puma Biotechnology, Inc. | Sr VP, Clinical Research &Dev | Sell | 2,293 | $33.24 | $76,208.08 | -7.3% | |
| Jul 6, 2015 | PBYI Puma Biotechnology, Inc. | Sr VP, Clinical Research &Dev | Sale+OE | 3,000 | $110.03 | $330,084.00 | -99.0% |